Obrindatamab Human Monoclonal Antibody
Obrindatamabis a research-grade recombinant antibody targeting CD276. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
CD276, B7-H3, Costimulatory molecule, B7H3, 4Ig-B7-H3, B7 homolog 3, CD276 antigen, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain
UniProt
P07766, Q5ZPR3
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human Humanized
Preservative
0.01M PBS, pH 7.4.
Isotype
ScFv with Domain Crossover, Kappa; Lambda
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC742853-500 1x 500 µL
CD54 / ICAM-1 (15.2), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741409-100 1x 100 µL
MART-1 / Melan-A / MLANA (Melanoma Marker) (MLANA/1409R), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041867-100 1x 100 µL
CD8A (Cytotoxic-&Suppressor T-Cell Marker) (rC8/468), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details